Ajanta Pharma Limited has informed the Exchange about Copy of Newspaper Publication
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has submitted copies of its newspaper publication to the stock exchanges, confirming that its financial results for the quarter and year ended 31st March 2025 were published on 1st May 2025 in the Mumbai editions of Business Standard and Navakal. This filing is a routine regulatory compliance under SEBI's Listing Regulations, which require listed companies to publish their quarterly and annual results in newspapers. The letter was signed by Gaurang Shah, Senior VP – Legal & Company Secretary. No new financial figures, strategic updates, or material changes are disclosed in this particular filing.
This is a procedural compliance filing with no direct impact on shareholders or the stock price. Investors seeking the actual Q4 and FY25 numbers should refer to the financial results already filed with the exchanges or the company website.